These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35318645)

  • 1. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.
    Kysilov B; Hrcka Krausova B; Vyklicky V; Smejkalova T; Korinek M; Horak M; Chodounska H; Kudova E; Cerny J; Vyklicky L
    Br J Pharmacol; 2022 Aug; 179(15):3970-3990. PubMed ID: 35318645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
    Vyklicky V; Krausova B; Cerny J; Ladislav M; Smejkalova T; Kysilov B; Korinek M; Danacikova S; Horak M; Chodounska H; Kudova E; Vyklicky L
    Front Mol Neurosci; 2018; 11():110. PubMed ID: 29681796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.
    Hubalkova P; Ladislav M; Vyklicky V; Smejkalova T; Hrcka Krausova B; Kysilov B; Krusek J; Naimová Z; Korinek M; Chodounska H; Kudova E; Cerny J; Vyklicky L
    J Neurosci; 2021 Mar; 41(10):2119-2134. PubMed ID: 33526476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.
    Hrcka Krausova B; Kysilov B; Cerny J; Vyklicky V; Smejkalova T; Ladislav M; Balik A; Korinek M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2020 Jul; 40(31):5922-5936. PubMed ID: 32611707
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
    Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.
    Kysilov B; Kuchtiak V; Hrcka Krausova B; Balik A; Korinek M; Fili K; Dobrovolski M; Abramova V; Chodounska H; Kudova E; Bozikova P; Cerny J; Smejkalova T; Vyklicky L
    Cell Mol Life Sci; 2024 Jan; 81(1):36. PubMed ID: 38214768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
    Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
    Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregn-5-en-3β-ol and androst-5-en-3β-ol dicarboxylic acid esters as potential therapeutics for NMDA hypofunction: In vitro safety assessment and plasma stability.
    Matousova M; Soucek R; Tloustova E; Slavikova B; Chodounska H; Mertlikova-Kaiserova H; Kudova E
    Steroids; 2019 Jul; 147():4-9. PubMed ID: 30296546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 11. Access of inhibitory neurosteroids to the NMDA receptor.
    Borovska J; Vyklicky V; Stastna E; Kapras V; Slavikova B; Horak M; Chodounska H; Vyklicky L
    Br J Pharmacol; 2012 Jun; 166(3):1069-83. PubMed ID: 22188257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
    Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
    J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of NMDA receptor regulation.
    Mony L; Paoletti P
    Curr Opin Neurobiol; 2023 Dec; 83():102815. PubMed ID: 37988826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
    Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
    Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.
    Korinek M; Candelas Serra M; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A; Smejkalova T
    Physiol Res; 2024 May; 73(Suppl 1):S413-S434. PubMed ID: 38836461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
    Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
    Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geometry and charge determine pharmacological effects of steroids on N-methyl-D-aspartate receptor-induced Ca(2+) accumulation and cell death.
    Weaver CE; Land MB; Purdy RH; Richards KG; Gibbs TT; Farb DH
    J Pharmacol Exp Ther; 2000 Jun; 293(3):747-54. PubMed ID: 10869372
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    XiangWei W; Jiang Y; Yuan H
    Curr Opin Physiol; 2018 Apr; 2():27-35. PubMed ID: 29756080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule.
    Vyklicky V; Krausova B; Cerny J; Balik A; Zapotocky M; Novotny M; Lichnerova K; Smejkalova T; Kaniakova M; Korinek M; Petrovic M; Kacer P; Horak M; Chodounska H; Vyklicky L
    Sci Rep; 2015 Jun; 5():10935. PubMed ID: 26086919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.